Egetis Therapeutics AB (STU:P0F) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:P0F Egetis Therapeutics AB STU:P0F
45 GF Score
Price €0.55
GF Value €0.48
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Egetis Therapeutics AB FFO per Share?

FFO per Share only applies to REITs.

STU:P0F
45GF Score
Egetis Therapeutics AB STU:P0F
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Egetis Therapeutics AB (STU:P0F) Overvalued in 2026?

Based on GuruFocus' analysis, Egetis Therapeutics AB stock appears to be overvalued. The current stock price of €0.55 is trading 14.2% above its estimated GF Value™ of €0.48. GuruFocus considers Egetis Therapeutics AB to be Modestly Overvalued.

Key valuation signals for STU:P0F:

  • FFO per Share:
  • GF Value™: €0.48 vs. price of €0.55 (14.2% above fair value)
  • GF Score™: 45/100 with 7 warning signs

No single metric tells the full story. See the STU:P0F stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Egetis Therapeutics AB Business Description

Other Exchanges PDPHF:USAEGTX:Sweden0ABW:UK
Address Grev Turegatan 11 C, Stockholm, SWE, 114 46
Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.
45GF Score

Get the complete analysis for STU:P0F

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.55
Price
€0.48
GF Value